March 7, 2023 – Terumo today announced results from a prospective registry study reinforcing the safety, efficacy and efficiency of radial access in visceral interventions (R.A.V.I.) for embolization procedures.
The R.A.V.I. registry evaluated outcomes of transradial access, an approach entering the body through the wrist rather than the groin, in patients undergoing visceral embolization procedures, demonstrating favorable safety and efficacy outcomes along with improved procedural efficiency.
"These registry results support the growing body of evidence for transradial access as a safe and effective alternative approach for visceral embolization procedures," said a Terumo representative. "Radial access offers meaningful benefits for both physicians and patients, including improved patient comfort and faster recovery."
The findings from the R.A.V.I. registry are expected to support continued adoption of radial access techniques among interventional radiologists performing visceral embolization procedures.
About Terumo
Terumo (TSE: 4543) is a leading global provider of medical products and solutions with net sales of 4 billion USD. Founded in 1921, Terumo employs over 30,000 associates worldwide, and its products and services are available in more than 160 countries and regions. Terumo's stated mission is "Contributing to Society through Healthcare."
